Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001062993-17-001520
Filing Date
2017-03-28
Accepted
2017-03-28 16:04:49
Documents
88
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10k.htm 10-K 664694
2 EXHIBIT 23.1 exhibit23-1.htm EX-23.1 1944
3 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 6018
4 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 6186
5 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2542
6 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 2704
13 GRAPHIC exhibi1.gif GRAPHIC 837
14 GRAPHIC exhibi2.gif GRAPHIC 669
15 GRAPHIC financialsx3x1.jpg GRAPHIC 1323
16 GRAPHIC financialsx3x2.jpg GRAPHIC 2174
  Complete submission text file 0001062993-17-001520.txt   6127139

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE igxt-20161231.xml EX-101.INS 726869
8 XBRL SCHEMA FILE igxt-20161231.xsd EX-101.SCH 198393
9 XBRL CALCULATION FILE igxt-20161231_cal.xml EX-101.CAL 45855
10 XBRL DEFINITION FILE igxt-20161231_def.xml EX-101.DEF 501421
11 XBRL LABEL FILE igxt-20161231_lab.xml EX-101.LAB 1286418
12 XBRL PRESENTATION FILE igxt-20161231_pre.xml EX-101.PRE 557200
Mailing Address 6425 ABRAMS VILLE SAINT LAURENT A8 H4S 1X9
Business Address 6425 ABRAMS VILLE SAINT LAURENT A8 H4S 1X9 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

EIN.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31187 | Film No.: 17719025
SIC: 2834 Pharmaceutical Preparations